NCT04965571

Brief Summary

Generalized epilepsy is rarely reported in patients with Wilson disease (WD) and lacks experience in clinical practice. We aim to provide better experience for the diagnosis and treatment for WD patients with epilepsy in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
Last Updated

July 16, 2021

Status Verified

July 1, 2021

Enrollment Period

7 years

First QC Date

July 5, 2021

Last Update Submit

July 11, 2021

Conditions

Keywords

Chineseclinical featuresgeneralized epilepsyoutcomeWilson's disease

Outcome Measures

Primary Outcomes (1)

  • Number of participants with treatment stop seizures attacks

    After standard treatment, the patients would stop attacks and get improved.

    12 month

Secondary Outcomes (1)

  • Number of participants with treatment have improved brain MRI

    12 month

Study Arms (1)

WD-seizures

Chinese WD patients with generalized epilepsy

Genetic: genetic test

Interventions

Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA)

WD-seizures

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Each patient was diagnosed with WD by clinical evaluation and genetic screening. Patients were given small doses of antiepileptic drugs (AEDs), followed by copper-chelation therapy when the seizures stabilized.

You may qualify if:

  • Each patient was diagnosed with WD by clinical evaluation and genetic screening and had ever experienced generalized epilepsy

You may not qualify if:

  • Not WD \& without generalized epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310000, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood samples

MeSH Terms

Conditions

Hepatolenticular DegenerationEpilepsy, Generalized

Interventions

Genetic Testing

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolism, Inborn ErrorsMetal Metabolism, Inborn ErrorsMetabolic DiseasesNutritional and Metabolic DiseasesEpilepsy

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesGenetic TechniquesGenetic ServicesHealth ServicesHealth Care Facilities Workforce and ServicesDiagnostic ServicesPreventive Health Services

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2021

First Posted

July 16, 2021

Study Start

September 1, 2010

Primary Completion

September 1, 2017

Study Completion

March 1, 2019

Last Updated

July 16, 2021

Record last verified: 2021-07

Locations